CAR T-Cell Therapy in Lymphomas
CAR T-Cell Therapy for Myeloma
CAR T-Cell Therapies for R/R ALL
Best Practices in Identifying and Managing CAR T-Cell–Mediated Toxicities
Date / Time
Renier J. Brentjens, MD, PhD
Department of Medicine
Weill Medical College of Cornell University
Department of Pharmacology
Weill Cornell Graduate School of Medical Sciences
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Frederick L. Locke, MD
Co-Leader, Moffitt Immuno-Oncology Program
Vice Chair and Associate Member
Department of Blood and Marrow Transplant and Cellular Immunotherapy
Immune Cell Therapy Program
Blood and Marrow Transplant and Cellular Immunotherapy
Moffitt Cancer Center
Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Professor of Medicine
Harvard Medical School
The goal of this activity is to improve the knowledge, competence, and performance of physicians and other healthcare providers so they can confidently and competently integrate CAR T-cell therapy into their clinical practices.
This program is intended for physicians and other healthcare providers who treat and manage patients with B-cell lymphomas, CLL, or multiple myeloma who are candidates for CAR T-cell therapies.
- Review the biologic principles underlying CAR T-cell therapy, structure and function of the CAR, and the mechanism of action of CAR T-cells
- Identify characteristics of patients who are candidates appropriate for treatment with CAR T-cell therapy
- Integrate into practice clinical trial data on CAR T-cell–based therapies for the treatment of patients with leukemia or B-cell lymphomas
- Evaluate emerging clinical data and novel approaches to CAR T-cell therapy for patients with myeloma or CLL
- Manage toxicities associated with CAR T-cell therapy using available guidelines and online clinical resources and tools
Continuing Medical and Professional Education
2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR are sponsored by the Medical College of Wisconsin.
ACCME Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.
AMA Credit Designation
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.00 hours participation for continuing education for allied health professionals.